Gene therapy is the future for the treatment of several, often life-threatening conditions. Several gene therapy assets are currently under trial targeting cancers, sensory organs, blood disease, and rare…

Aptamers are increasingly being employed across the discovery and development pipeline. From drug screening to critical assay reagents and as targeted therapeutics, aptamers are being applied to support a…

Novel diagnostic platforms are bringing possibilities for improved patient care and reduced healthcare costs. We spoke with Dr Edgar Goluch, the CEO and founder of QSM Diagnostics,

In the recently published paper in Talenta from Dr Mark Platt and the team at Loughborough University, they demonstrate a novel approach for aptamer biosensors to detect…

Detecting and quantifying small molecule analytes can be difficult. Our specially designed displacement approach allows us to select aptamers that can directly be used in various biosensor platforms for…

Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…

AptaBlot – increasing the utility of Western Blotting Western Blotting is a powerful technique used to detect and identify proteins. Antibodies have traditionally been used as the detection…

Flow Cytometry Flow Cytometry is a technique used to identify biomarkers on cell surfaces and intracellular molecules. Most flow cytometers use fluorescently labelled antibodies to differentiate between cells…

There is a growing need for easy to use, point of care tests. A technology where aptamers can be used to achieve this is in lateral flow assays. A…

One of the key benefits of using aptamers instead of antibodies is how you store and use the reagent. Over the past 60 years the stability of oligonucleotides has…